🚀 VC round data is live in beta, check it out!
BB Biotech Valuation Multiples
Discover revenue and EBITDA valuation multiples for BB Biotech and similar public comparables like Denali Therapeutics, Xenon Pharmaceuticals, Santen Pharmaceutical, United Laboratories International and more.
BB Biotech Overview
About BB Biotech
BB Biotech AG is a part of the healthcare sector in Switzerland. Its primary activity includes making investments, especially in the biotechnology market, and is one of the investors in the field of biotechnology. The focus of the investments is on those listed companies that focus on the development and marketing of novel drugs with a clear value for the healthcare system. Geographically company operates in the USA, Netherlands, Singapore, Great Britain, Canada, Switzerland, Curacao, and British Virgin Island.
Founded
1993
HQ
Employees
86
Website
Sectors
Financials (LTM)
EV
$3B
BB Biotech Financials
BB Biotech reported last 12-month revenue of $593B and EBITDA of $126M.
In the same LTM period, BB Biotech generated $126M in EBITDA and $126M in net income.
BB Biotech P&L
In the most recent fiscal year, BB Biotech reported revenue of $782B and EBITDA of $122M.
BB Biotech expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $593B | XXX | $782B | XXX | XXX | XXX |
| EBITDA | $126M | XXX | $122M | XXX | XXX | XXX |
| EBITDA Margin | 0% | XXX | 0% | XXX | XXX | XXX |
| EBIT Margin | 0% | XXX | 0% | XXX | XXX | XXX |
| Net Profit | $126M | XXX | $724M | XXX | XXX | XXX |
| Net Margin | 0% | XXX | 0% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
BB Biotech Stock Performance
BB Biotech has current market cap of $3B, and enterprise value of $3B.
BB Biotech's stock price is $59.31.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $3B | $3B | -0.5% | XXX | XXX | XXX | $13.13 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialBB Biotech Valuation Multiples
BB Biotech trades at 0.0x EV/Revenue multiple, and 25.9x EV/EBITDA.
BB Biotech Financial Valuation Multiples
As of March 29, 2026, BB Biotech has market cap of $3B and EV of $3B.
Equity research analysts estimate BB Biotech's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
BB Biotech has a P/E ratio of 25.9x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $3B | XXX | $3B | XXX | XXX | XXX |
| EV (current) | $3B | XXX | $3B | XXX | XXX | XXX |
| EV/Revenue | 0.0x | XXX | 0.0x | XXX | XXX | XXX |
| EV/EBITDA | 25.9x | XXX | 26.9x | XXX | XXX | XXX |
| EV/EBIT | 25.9x | XXX | 26.9x | XXX | XXX | XXX |
| P/E | 25.9x | XXX | 4.5x | XXX | XXX | XXX |
| EV/FCF | 10.9x | XXX | 8.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified BB Biotech Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
BB Biotech Margins & Growth Rates
BB Biotech's revenue in the last 12 month declined by (100%).
BB Biotech's revenue per employee in the last FY averaged $6899.7M.
BB Biotech's rule of 40 is (100%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
BB Biotech's rule of X is (250%) (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
BB Biotech Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | (100%) | XXX | (100%) | XXX | XXX | XXX |
| EBITDA Margin | 0% | XXX | 0% | XXX | XXX | XXX |
| EBITDA Growth | 5% | XXX | 16% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | (100%) | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | (250%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $6899.7M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 0% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 0% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 0% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
BB Biotech Public Comps
See public comps and valuation multiples for other Biopharmaceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Denali Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| Xenon Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
| Santen Pharmaceutical | XXX | XXX | XXX | XXX | XXX | XXX |
| United Laboratories International | XXX | XXX | XXX | XXX | XXX | XXX |
| Edgewise Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
BB Biotech M&A Activity
BB Biotech acquired XXX companies to date.
Last acquisition by BB Biotech was on XXXXXXXX, XXXXX. BB Biotech acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by BB Biotech
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialBB Biotech Investment Activity
BB Biotech invested in XXX companies to date.
BB Biotech made its latest investment on XXXXXXXX, XXXXX. BB Biotech invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by BB Biotech
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout BB Biotech
| When was BB Biotech founded? | BB Biotech was founded in 1993. |
| Where is BB Biotech headquartered? | BB Biotech is headquartered in Switzerland. |
| How many employees does BB Biotech have? | As of today, BB Biotech has over 86 employees. |
| Is BB Biotech publicly listed? | Yes, BB Biotech is a public company listed on SIX Swiss Exchange. |
| What is the stock symbol of BB Biotech? | BB Biotech trades under BION ticker. |
| Who are competitors of BB Biotech? | BB Biotech main competitors are Denali Therapeutics, Xenon Pharmaceuticals, Santen Pharmaceutical, United Laboratories International. |
| What is the current market cap of BB Biotech? | BB Biotech's current market cap is $3B. |
| What is the current revenue of BB Biotech? | BB Biotech's last 12 months revenue is $593B. |
| What is the current revenue growth of BB Biotech? | BB Biotech revenue growth (NTM/LTM) is (100%). |
| What is the current EV/Revenue multiple of BB Biotech? | Current revenue multiple of BB Biotech is 0.0x. |
| Is BB Biotech profitable? | Yes, BB Biotech is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of BB Biotech? | BB Biotech's last 12 months EBITDA is $126M. |
| What is BB Biotech's EBITDA margin? | BB Biotech's last 12 months EBITDA margin is 0%. |
| What is the current EV/EBITDA multiple of BB Biotech? | Current EBITDA multiple of BB Biotech is 25.9x. |
| What is the current FCF of BB Biotech? | BB Biotech's last 12 months FCF is $301M. |
| What is BB Biotech's FCF margin? | BB Biotech's last 12 months FCF margin is 0%. |
| What is the current EV/FCF multiple of BB Biotech? | Current FCF multiple of BB Biotech is 10.9x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.